Armata Pharmaceuticals Inc (ARMP) Institutional Investor Snapshot (54 Funds, Q2 2026)

ARMP ranks #5973 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

ARMP is a disclosed holding of Israel Englander (Millennium Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

54 institutions disclose a position in ARMP, but none treat it as a major bet — even Dauntless Investment Group, LLC, its most concentrated holder, allocates just 1.0% of its own portfolio to it.

SeaCrest Wealth Management, LLC has trimmed its ARMP position for two straight quarters, cutting it by $271.4K while still holding $153.8K.

ARMP is down 4.4% today, but institutions show net buying of $10.0M this quarter — a divergence between today's price move and the underlying institutional flow.

ARMP reported a net loss of $173.8M in its latest fiscal year.

• Not yet profitable — net loss of $173.8M in the latest fiscal year
• Revenue declined 5.2% year over year
• Net income declined year over year, from -$18.9M to -$173.8M
• Operating cash flow was negative, using $25.8M in cash
• Current ratio of 1.19x — below the conventional 1.5x liquidity buffer